{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:22:22Z","timestamp":1750540942770},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 60-year-old man with suspected right renal cell carcinoma underwent <jats:sup>18<\/jats:sup>F-FDG PET\/CT and <jats:sup>18<\/jats:sup>F prostate-specific membrane antigen (PSMA) 1007 PET\/CT scan. Compared with the <jats:sup>18<\/jats:sup>F-FDG PET\/CT scan, <jats:sup>18<\/jats:sup>F-PSMA 1007 PET\/CT showed intense tracer concentration in the primary tumor in the right kidney and intense tracer concentration consistently in all lung nodules. Unlike noted in previous pilot studies with <jats:sup>68<\/jats:sup>Ga-PSMA, we observed that the primary renal tumor also showed intense tracer avidity with <jats:sup>18<\/jats:sup>F-PSMA 1007. <jats:sup>18<\/jats:sup>F-PSMA 1007 PET\/CT may provide preoperative insight into possible etiology, histopathological probability of tumor type, staging information, and theranostic potentials in evaluation of suspected renal cell carcinoma.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003002","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T18:30:49Z","timestamp":1586197849000},"page":"377-378","source":"Crossref","is-referenced-by-count":21,"title":["18F-PSMA 1007 in Suspected Renal Cell Carcinoma"],"prefix":"10.1097","volume":"45","author":[{"given":"Fahad","family":"Marafi","sequence":"first","affiliation":[{"name":"Jaber Alahmad Centre for Molecular Imaging, Shuwaikh, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Sasikumar","sequence":"additional","affiliation":[{"name":"St Gregorios International Cancer Care Centre, Chengannur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullatif","family":"Al-Terki","sequence":"additional","affiliation":[{"name":"Al-Amiri General Hospital, Kuwait City."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Alfeeli","sequence":"additional","affiliation":[{"name":"Jaber Alahmad Centre for Molecular Imaging, Shuwaikh, Kuwait"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.urology.2007.03.025","article-title":"Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms","volume":"70","year":"2007","journal-title":"Urology"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00259-014-2766-y","article-title":"(68)Ga-PSMA PET\/CT imaging of metastatic clear cell renal cell carcinoma","volume":"41","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13550-016-0231-6","article-title":"Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour","volume":"6","year":"2016","journal-title":"EJNMMI Res"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00259-016-3360-2","article-title":"Diagnostic potential of PET\/CT using a (68)Ga-labelled prostate-specific membrane antigen ligand in whole-body staging of renal cell carcinoma: initial experience","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/1754-9485.12590","article-title":"Utility of (68) Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma","volume":"61","year":"2017","journal-title":"J Med Imaging Radiat Oncol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1097\/RLU.0000000000001394","article-title":"Complimentary pattern of uptake in 18F-FDG PET\/CT and 68Ga-prostate-specific membrane antigen PET\/CT in a case of metastatic clear cell renal carcinoma","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib7-20230925","first-page":"6","article-title":"More advantages in detecting bone and soft tissue metastases from prostate cancer using (18)F-PSMA PET\/CT","volume":"22","year":"2019","journal-title":"Hell J Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00259-016-3447-9","article-title":"(18)F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:03:56Z","timestamp":1695621836000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003002","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,24]]}}}